Global Nicotine Replacement Therapy (NRT) Products Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Nicotine Replacement Therapy (NRT) Products market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Nicotine Replacement Therapy (NRT) Products market."
Nicotine replacement therapy (NRT) is a medically-approved way to take nicotine by means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting smoking by about 50% to 70%.Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of more than one type of NRT at a time may increase effectiveness.

The global Nicotine Replacement Therapy (NRT) Products market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nicotine Replacement Therapy (NRT) Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nicotine Replacement Therapy (NRT) Products market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Pfizer
    Cipla
    Novartis
    GlaxoSmithKline
    Takeda
    McNeil
    Revolymer
    Imperial Tobacco
    VMR products

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Sprays
    Inhalers
    Chewing gums
    Transdermal patches
    Lozenges
    Sublingual tablets

Segment by Application
    Home
    Hospital